Add like
Add dislike
Add to saved papers

Epidemiology of moyamoya disease in China: a single-center, population-based study.

World Neurosurgery 2018 November 5
BACKGROUND: To our knowledge, no previous study has described the nationwide epidemiological features of moyamoya disease in China. We describe the epidemiological features, including the relative prevalence, age distribution, gender distribution, and initial clinical manifestations of patients with moyamoya disease treated at a single institution in China.

METHODS: Our cohort included 4,128 patients with moyamoya disease. Their demographic and clinical characteristics were obtained by retrospective chart review.

RESULTS: The median age for the onset of symptoms was 30.36 years. The age distribution of patients with MMD was bimodal, with the highest peak detection rate at 35-45 years of age and a smaller peak at 5-9 years of age. The ratio of female to male patients was 1:1. The disease occurred mainly in the Han people and was rarely seen in minority nationalities. In our cohort, transient ischemic attack was the most common initial clinical manifestation (48.13%). The other initial manifestations included infarction (22.62%), hemorrhage (16.45%), and headache 230/4128 (5.57%). In north and northeast China, the ischemic type was more predominate while the hemorrhagic type was relatively rare. However, the percentage of hemorrhagic type in East China was higher than anywhere else in China.

CONCLUSIONS: This study confirmed some unique epidemiological features as the studies previously reported in China, but also it revealed some new sight and tendency about moyamoya in China. As a lack of national epidemiologic studies, this study indicated the outline of moyamoya in China.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app